IP Library › Assignment 070250/0077
Patent Assignment
Reel/Frame 070250/0077

Assignment of Assignor's Interest

Recorded: 2025-02-18 Pages: 6
Assignor
TABUTEAU, HERRIOT
Executed: 2025-02-13
Assignee
AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR, NEW YORK, NEW YORK, 10007
Covered Properties (19)
Pharmaceutical Compositions Comprising Meloxicam
Application: 18/950,743 →
Publication: US US20250195534A1
Use of Reboxetine to Treat Nervous System Disorders
Application: 63/725,385 →
Pharmaceutical Compositions Comprising Meloxicam
Application: 63/730,831 →
Pharmaceutical Compositions Comprising Bupropion and Cysteine
Application: 18/984,644 →
Publication: US US20250248952A1
Microparticles Containing Bupropion
Application: 18/988,215 →
Publication: US US20250235414A1
Polymorph Forms of Reboxetine
Application: 63/738,431 →
Dosage Forms Containing Reboxetine Having Improved Purity
Application: 63/738,418 →
2-((2-Ethoxyphenoxy)(Phenyl)Methyl)-4-Nitrosomorpholine
Application: 63/738,428 →
Pharmaceutical Compositions Comprising Uniform Blends of Reboxetine
Application: 63/738,412 →
Use of Reboxetine to Treat Narcolepsy
Application: 19/024,709 →
Publication: US US20250161316A1
Pharmaceutical Compositions Comprising Meloxicam
Application: 19/030,296 →
Publication: US US20250205246A1
Dosage Forms Containing Esreboxetine Having Improved Purity
Application: 63/747,811 →
(S)-2-((S)-(2-Ethoxyphenoxy)(Phenyl)Methyl)-4-Nitrosomorpholine
Application: 63/747,812 →
Pharmaceutical Compositions Comprising Uniform Blends of Esreboxetine
Application: 63/747,814 →
Pharmaceutical Compositions Comprising Meloxicam
Application: 63/751,707 →
Pharmaceutical Compositions Comprising Meloxicam
Application: 63/751,735 →
Compounds and Combinations Thereof for Treating Depression in Patients
Use of Esreboxetine to Treat Nervous System Disorders
Pharmaceutical Compositions Comprising Meloxicam
Application: 63/730,838 →
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Assignment of Assignor's Interest Mar 4, 2026
From: AXSOME THERAPEUTICS, INC.
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 073973/0726 →